Nuevolution A/S (Copenhagen, Denmark) is a drug discovery company dedicated to revolutionize fragment- and high throughput-based lead discovery. The company’s drug discovery platform, tChemetics™, excels at being more cost-efficient, faster and better than conventional methods in identifying drug leads to virtually any therapeutic target. Nuevolution is successfully exploiting its platform technology both through internal programs, fully partner-funded programs and through collaborative projects.
Søren Lemonius, MSc

Managing General Partner

Mobile: +45 40 81 48 89